BY DR TIM SANDLE | PHARMACEUTICAL MICROBIOLOGY AND CONTAMINATION CONTROL EXPERT
12th OCTOBER
Raw materials represent one of the most significant and often underestimated sources of microbial contamination entering pharmaceutical and biotechnology manufacturing facilities.
While considerable attention is directed towards environmental controls, personnel practices and equipment qualification, contamination control strategies can be weakened if the microbiological risks associated with incoming materials are not adequately understood and controlled [1].
However, not all raw materials present the same level of microbial risk. Factors such as material origin, manufacturing process, moisture content, storage conditions, transportation arrangements and supplier quality systems influence both the likelihood and nature of microbial contamination. Consequently, a risk-based approach is required when establishing specifications, supplier qualification programmes and incoming testing strategies.
This article reviews the principal categories of pharmaceutical raw materials and examines how microbiological risk varies according to material characteristics, with particular emphasis on natural materials, synthetic compounds, mineral-derived substances, moisture levels and supplier controls.
Raw materials are frequently contaminated with low levels of microorganisms acquired from environmental exposure during harvesting, mining, synthesis, processing, transportation or storage. Although many manufacturing processes include purification, filtration or sterilisation steps, microorganisms (or their metabolic products) may still pose risks.
These risks include [2]:
• Introduction of objectionable microorganisms into non-sterile products
• Increased bioburden challenging sterilisation processes
• Presence of spore-forming organisms
• Introduction of endotoxins from Gram-negative bacteria
• Introduction of fungal contamination and mycotoxins
• Biofilm-forming microorganisms entering water-based processes
• Batch rejection and manufacturing disruptions
The level of concern depends upon the nature of the product being manufactured and the processing steps available to reduce microbial contamination.
Important EM programme elements include:
The level of concern depends upon the nature of the product being manufactured and the processing steps available to reduce microbial contamination.
Among all categories of raw materials, those derived from natural sources generally present the highest microbiological risk. Natural materials include:
• Plant extracts
• Herbal materials
• Cellulose derivatives
• Starches
• Sugars
• Animal-derived materials
• Fermentation-derived ingredients
These materials originate from environments naturally inhabited by large and diverse microbial populations. Soil microorganisms frequently contaminate agricultural products, introducing bacteria such as Bacillus, Paenibacillus and Clostridium species, together with fungal contaminants including Aspergillus and Penicillium. Plant-derived materials often carry substantial microbial loads due to [3]:
• Exposure to soil
• Irrigation water quality
• Harvesting practices
• Storage conditions
• Seasonal variability
Animal-derived materials present additional concerns because they contain nutrients capable of supporting microbial growth. Historically, gelatine, peptones and other animal-derived materials have been associated with elevated bioburden levels when controls are inadequate.
Fermentation-derived materials occupy an intermediate position. While produced under controlled manufacturing conditions, they are intentionally generated through microbial processes and therefore require robust purification and control programmes to ensure unwanted microorganisms are absent. For natural materials, supplier qualification and microbiological specifications become particularly important because contamination levels may vary significantly between lots. In addition, effective test methods are required as organisms like Bacillus tend to clump which can lead to an under-estimation of the count [4].
Mineral-derived materials generally present lower microbiological risks compared with substances derived from biological sources. Examples include:
• Talc
• Kaolin
• Silica
• Bentonite
• Calcium carbonate
• Magnesium stearate derived from mineral precursors
Many mineral products originate from geological environments that provide limited nutrients for microbial growth. However, this does not imply the absence of contamination. Mining operations expose materials to environmental organisms commonly found in soil and dust. Consequently, spore-forming bacteria are frequently recovered from mineral products. Organisms such as Bacillus and related genera demonstrate persistence in dry mineral environments.
An important characteristic of mineral materials is that while microbial numbers may be relatively low, surviving organisms are often environmentally robust and resistant to adverse conditions. This can create challenges where materials are introduced into aqueous manufacturing systems. Mineral materials should therefore be evaluated not only according to total microbial count but also according to the types of microorganisms likely to survive within them.
Synthetic chemicals generally represent the lowest microbiological risk category. Examples include:
• Chemically synthesised active pharmaceutical ingredients.
• Organic solvents
• Synthetic polymers
• Process reagents
• Laboratory chemicals
Many synthetic manufacturing processes involve conditions incompatible with microbial survival, including:
• Elevated temperatures
• Extreme pH
• Organic solvent exposure
• High pressures
• Purification steps
As a result, many synthetic materials exhibit very low recoverable microbial counts. However, low risk is not synonymous with no risk. Contamination may occur during:
• Post-synthesis handling
• Packaging operations
• Warehousing
• Transportation
• Repackaging by distributors
Certain synthetic materials are also hygroscopic, allowing moisture uptake during storage, potentially creating conditions favourable to microbial survival. Therefore, manufacturers should avoid assuming microbiological safety solely on the basis of chemical synthesis.
One of the strongest predictors of microbial risk is water activity. Microorganisms require available water to grow. Consequently, materials can often be stratified according to their moisture characteristics [5].
Dry materials
Examples include:
• Powders
• Salts
• Minerals
• Freeze-dried materials
Dry products generally do not support active microbial multiplication. Nevertheless, they may contain viable microorganisms that survive in dormant states. Particularly important are:
• Bacterial spores
• Fungal spores
• Desiccation-resistant organisms
The apparent microbiological stability of dry materials may therefore disguise the presence of contamination capable of proliferating when introduced into aqueous manufacturing environments.
Intermediate moisture materials
Materials with moderate water activity present a more complex risk profile. Examples include:
• Certain granulations
• Semi-dried botanical products
• Hygroscopic powders
These materials may support the survival of specialised microorganisms, including xerophilic fungi and osmotolerant species. Risk assessment should therefore consider both total moisture content and water activity rather than relying solely upon percentage moisture.
Wet materials
Aqueous materials generally present the highest microbial risk. Examples include:
• Liquid excipients
• Aqueous solutions
• Suspensions
• Process intermediates
Water availability allows microbial proliferation if contamination occurs. Particular concern surrounds:
• Gram-negative bacteria
• Biofilm-forming organisms
• Waterborne environmental species
Where wet materials are stored for extended periods, appropriate hold-time studies and microbial monitoring become essential.
The microbiological quality of raw materials is heavily influenced by supplier management systems. Even low-risk materials can become contaminated through poor manufacturing practices. Conversely, robust quality systems can significantly reduce contamination risks associated with naturally derived materials. Supplier assessment should include evaluation of:
• Manufacturing controls
• Environmental monitoring programmes
• Cleaning and sanitation systems
• Pest management programmes
• Personnel training
• Water system controls
• Storage conditions
• Packaging controls
• Transportation arrangements
Modern supplier qualification programmes increasingly adopt risk-based approaches, allocating greater scrutiny to suppliers providing microbiologically sensitive materials. Audit programmes should verify not only compliance with procedural requirements but also scientific understanding of contamination control principles.
Microbiological risks do not end once materials leave the supplier. Transportation may introduce contamination through:
• Damaged packaging
• Humidity ingress
• Condensation
• Cross-contamination
• Poor vehicle hygiene
Long shipping routes can be particularly problematic for hygroscopic materials exposed to changing environmental conditions. Storage conditions are equally important. Warehouses with inadequate temperature and humidity control can create favourable conditions for microbial proliferation, especially where materials are stored for prolonged periods. Therefore, supplier qualification should extend beyond manufacturing capabilities and include logistics management.
Not every material requires the same microbiological testing regime. A risk-based approach may classify materials as [6]:
High risk
• Animal-derived materials
• Botanical materials
• Fermentation-derived ingredients
• Wet materials
These typically justify extensive microbiological testing and tighter supplier oversight.
Medium risk
• Mineral-derived materials
• Hygroscopic materials
• Materials exposed to environmental handling
These generally require routine monitoring and periodic trend evaluation [7, 8].
Low risk
• Highly purified synthetic chemicals
• Materials produced through robust chemical synthesis
• Materials with low water activity
These may require reduced testing once supplier capability and historical performance have been demonstrated. Testing programmes should remain dynamic and responsive to trend data, supplier performance and process knowledge [9].
Microorganisms cannot be assessed solely through total count methods. Additional considerations include [10]:
• Endotoxin contamination
• Objectionable microorganisms
• Antimicrobial-resistant organisms
• Fungal contaminants
• Mycotoxins
• Viable but non-culturable microorganisms
Advanced microbial identification methods and risk-based contamination control strategies are becoming increasingly important for understanding the true microbiological risks associated with incoming raw materials. Supplier partnerships, enhanced material characterisation and contamination control strategies aligned with Quality Risk Management (QRM) principles offer the most effective means of controlling raw-material-associated microbiological risk.
Microbiological risk associated with pharmaceutical raw materials varies considerably according to material origin, manufacturing process, moisture content and supplier controls. Natural-origin materials generally present the greatest risk, owing to their exposure to environmental microorganisms and intrinsic variability. Mineral materials typically carry lower numbers of microorganisms but may contain environmentally resistant species, particularly bacterial spores. Synthetic materials usually pose the lowest risk but remain vulnerable to contamination during handling and distribution.
Among all risk factors, water activity remains one of the most powerful determinants of microbial survival and growth. Equally important are supplier quality systems, transportation arrangements and storage conditions, all of which influence the microbial status of incoming materials.
A scientifically justified, risk-based approach to supplier qualification, material classification and microbiological testing enables manufacturers to allocate resources effectively while maintaining appropriate contamination control. As regulatory expectations continue to evolve towards holistic contamination control strategies, understanding the distinct microbial risks associated with different categories of raw materials remains a fundamental component of pharmaceutical quality assurance.
1. Clontz, L. (2008). Microbial Limit and Bioburden Tests: Validation Approaches and Global Requirements. CRC Press.
2. Denyer, S.P., Baird, R.M. & Hodges, N.A. (2020). Hugo and Russell's Pharmaceutical Microbiology (9th Edition). Wiley-Blackwell.
3. Lund, B.M., Baird-Parker, T.C. & Gould, G.W. (2000). The Microbiological Safety and Quality of Food. Aspen Publishers.
4. Sandle, T. (2013). ‘Bacterial Adhesion: An Introduction.’ European Journal of Parenteral and Pharmaceutical Sciences, 18(3), 87-95.
5. Jimenez, L. (2007). ‘Microbial Diversity in Pharmaceutical Product Recalls and Environments.’ PDA Journal of Pharmaceutical Science and Technology, 61(5), 383-399.
6. Sutton, S.V.W. (2011). ‘The Most Probable Number Method and Its Uses in Enumeration, Qualification, and Validation.’ Journal of Validation Technology, 17(3), 35-38.
7. Whyte, W., Eaton, T. & Hallworth, T. (2010). ‘Methods for Assessing the Bacterial Contamination of Surfaces and Cleanroom Materials.’ European Journal of Parenteral and Pharmaceutical Sciences, 15(2), 43-52.
8. Denyer, S.P., Maillard, J.Y. & Hammond, S.A. (2011). ‘Microbiological Contamination Control in Pharmaceutical Manufacturing.’ Pharmaceutical Technology Europe, 23(8), 20-27.
9. Bloomfield, S.F., Exner, M., Signorelli, C., Nath, K.J. & Scott, E.A. (2012). ‘The Chain of Infection Transmission in Healthcare and Pharmaceutical Settings.’ International Scientific Forum on Home Hygiene Review.
10. Sandle, T. (2015). ‘Assessing Process Hold Times for Microbial Risks: Bioburden and Endotoxin.’ IVT Network Journal, 11(6), 28-34.